Theriva Biologics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Theriva Biologics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Theriva Biologics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 19.4M shares, a 27.9% increase year-over-year.
  • Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 16.1M shares, a 5.09% increase from 2022.
  • Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.3M shares, a 25.8% increase from 2021.
  • Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 12.2M shares, a 35.9% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 19.4M +4.23M +27.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 17.1M +2.02M +13.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 16.1M +780K +5.09% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 17M +1.2M +7.57% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 15.2M -678K -4.28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 15.1M +1.3M +9.44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 15.3M +3.14M +25.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 15.8M +2.64M +20% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 15.8M +2.64M +20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 13.8M -77M -84.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 12.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 13.2M -6.19M -31.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 13.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 90.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 19.4M +2.59M +15.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q3 2019 16.8M +12.8M +317% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-04
Q2 2019 16.5M +12.8M +347% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 15.7M +12M +326% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 13.4M +9.77M +266% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-27
Q3 2018 4.03M +363K +9.91% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 3.68M +169K +4.81% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 3.67M +318K +9.47% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 3.67M -100M -96.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 3.67M -87.8M -96% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 3.51M -87.5M -96.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 3.36M -87.5M -96.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 104M +13M +14.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 91.4M +5.47M +6.36% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-22
Q2 2016 91M +18.3M +25.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-22
Q1 2016 90.8M +18.2M +25% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-22
Q4 2015 90.8M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 86M +27.5M +47.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 72.7M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 72.7M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q3 2014 58.5M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2011 27.9M +6.18M +28.5% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-15
Q2 2010 21.7M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.